费舍尔公司将微生物业务以1075亿美元的价格出售给阿斯托. Thermo Fisher sells microbiology business to Astorg for $1.075B.

泰尔摩·费舍尔科学公司同意将其微生物业务出售给私募股权公司Astorg,价格约为1075亿美元. Thermo Fisher Scientific agreed to sell its microbiology business to private equity firm Astorg for about $1.075 billion. 这笔预计将在2026年下半年完成的交易,将帮助Thermo Fisher专注于增长较快的细分市场. The deal, expected to close in the second half of 2026, will help Thermo Fisher focus on higher-growth segments. 收益将用于加强公司的资产负债表和未来投资. The proceeds will be used to strengthen the company's balance sheet and fund future investments.